Related Tags >> Avastin FDA Lucentis Biogen Idec

Genentech News

Most Popular Genentech Story

Roche wins landmark approval for targeted cancer drug vismodegib

January 30, 2012 — 11:30am ET | By John Carroll

Roche ($RHHBY) and Genentech won a landmark approval for the cancer drug vismodegib today. After gaining significant efficacy data from a Phase II study on basal cell carcinoma, the drug giant not Read more...

Genentech Press Releases

Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lucentis
Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lu
Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors
BioSpace Spotlights Northwest's Life Science Community

Latest Headlines

FDA rewards Roche with priority review for blockbuster cancer drug
February 8, 2012
Severin Schwan - The 25 most influential people in biopharma today
February 7, 2012
Susan Desmond-Hellmann - The 25 most influential people in biopharma today
February 7, 2012
Roche wins landmark approval for targeted cancer drug vismodegib
January 30, 2012
UPDATED: Illumina soars as Roche's hostile bid highlights two hot trends
January 25, 2012
Constellation inks $95M discovery deal, buyout option with Genentech
January 16, 2012
Fast-growing Forma grabs $815M cancer discovery deal with Boehringer
January 5, 2012
Regeneron finally captures an FDA OK with new eye drug
November 21, 2011
Exclusive: Tolerx cuts staff, auctioning assets after PhIII failure
October 7, 2011
Survey: Vertex, Regeneron top list of biopharma employers
September 16, 2011
Array adds $713M cancer drug pact with Genentech to deal roster
August 9, 2011
Genentech drug looks promising in early breast-cancer trial
August 5, 2011
Genentech leaves the numbers blank in Forma deal
June 27, 2011
Roche preps vismodegib app after Ph2 skin cancer success
June 20, 2011
Genentech scientists blaze a trail into the brain for antibodies
May 26, 2011
Roche cancer programs angle for a starring role at ASCO
May 18, 2011
Genentech sees promise in combining experimental cancer drugs
April 4, 2011
GDC-0449 - 10 promising late-stage cancer drugs
April 4, 2011
Spectrum partners up on new program for rituximab biosimilar
January 5, 2011
Adimab inks deals with Lilly, Genentech and HGS
December 15, 2010

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events